Drug Shortage Report for EPINEPHRINE INJECTION USP

Last updated on 2024-03-28 History
Report ID 200978
Drug Identification Number 02435810
Brand name EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC SUBCUTANEOUS INTRAVENOUS INTRATRACHEAL INTRAMUSCULAR INTRACARDIAC
Packaging size 1mL
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-09-01
Actual start date
Estimated end date 2024-03-25
Actual end date 2024-03-27
Shortage status Resolved
Updated date 2024-03-28
Company comments Product on allocation at distributors.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-03-28 French Compare
v9 2024-03-28 English Compare
v8 2024-03-19 French Compare
v7 2024-03-19 English Compare
v6 2024-02-05 French Compare
v5 2024-02-05 English Compare
v4 2023-09-02 English Compare
v3 2023-08-03 French Compare
v2 2023-08-03 English Compare
v1 2023-08-03 English Compare

Showing 1 to 10 of 10